🇺🇸 Emcyt in United States

FDA authorised Emcyt on 24 December 1981

Marketing authorisations

FDA — authorised 24 December 1981

  • Marketing authorisation holder: PHARMACIA AND UPJOHN
  • Status: approved

FDA — authorised 24 December 1981

  • Application: NDA018045
  • Marketing authorisation holder: PHARMACIA AND UPJOHN
  • Local brand name: EMCYT
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

Emcyt in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Emcyt approved in United States?

Yes. FDA authorised it on 24 December 1981; FDA authorised it on 24 December 1981.

Who is the marketing authorisation holder for Emcyt in United States?

PHARMACIA AND UPJOHN holds the US marketing authorisation.